Biodelivery Sciences International Inc Revenue Growth Rates (BDSI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Biodelivery Sciences International Inc   (NASDAQ: BDSI)
 

BDSI's Revenue Growth by Quarter and Year

Biodelivery Sciences International Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BDSI Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December 43.15
3rd Quarter September 41.09
2nd Quarter June 41.44
1st Quarter March 41.02
FY 166.70

BDSIs Annual Revenue
Biodelivery Sciences International Inc 's Revenue in the fiscal year 2021 $ 166.70 millions
Biodelivery Sciences International Inc 's Revenue in the fiscal year 2020 $ 156.47 millions
Biodelivery Sciences International Inc 's Revenue in the fiscal year 2019 $ 111.39 millions
Biodelivery Sciences International Inc 's Revenue in the fiscal year 2018 $ 55.64 millions
Biodelivery Sciences International Inc 's Revenue in the fiscal year 2017 $ 61.99 millions




BDSI Revenue fourth quarter 2021 Y/Y Growth Comment
Biodelivery Sciences International Inc reported Revenue growth of 2.33% year on year in the fourth quarter 2021, to $ 43.15 millions, this is lower than Biodelivery Sciences International Inc 's recent average Revenue surge of 134.4%.

Looking into fourth quarter 2021 results within Major Pharmaceutical Preparations industry 152 other companies have achieved higher Revenue growth. While Biodelivery Sciences International Inc ' s Revenue increase of 2.33% ranks overall at the positon no. 2680 in the fourth quarter 2021.


BDSI Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December 2.33 % 33.28 % 75.49 % 44.12 %
3rd Quarter September 4.18 % 30.12 % 114.05 % 25.87 %
2nd Quarter June 13.29 % 23.25 % 143.68 % 39.36 %
1st Quarter March 7.16 % 93.63 % 75.27 % -61.74 %
FY   6.54 % 40.46 % 100.18 % -

Financial Statements
Biodelivery Sciences International Inc 's fourth quarter 2021 Revenue $ 43.15 millions BDSI's Income Statement
Biodelivery Sciences International Inc 's fourth quarter 2020 Revenue $ 42.17 millions Quarterly BDSI's Income Statement


BDSI Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December 5.02 % 6.92 % 4.39 % 27.33 %
3rd Quarter September -0.84 % 7.82 % 2.12 % 16.26 %
2nd Quarter June 1.02 % -4.44 % 50.13 % 7.98 %
1st Quarter March -2.73 % 20.99 % 9.65 % -9.83 %
FY (Year on Year)   6.54 % 40.46 % 100.18 % -


Back to BDSI Growth rate Comparisons >> Back to BDSI Growth rate Comparisons >>


Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #153
Healthcare Sector #375
Overall #2680

Revenue Y/Y Growth Statistics
High Average Low
1175.59 % 134.4 % -90.18 %
(Mar 31 2014)   (Mar 31 2013)
Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #153
Healthcare Sector #375
Overall #2680
Revenue Y/Y Growth Statistics
High Average Low
1175.59 % 134.4 % -90.18 %
(Mar 31 2014)   (Mar 31 2013)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Biodelivery Sciences International Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2508.02 % 115.21 % -90.56 %
(Dec 31 2015)  


BDSI's IV. Quarter Q/Q Revenue Comment
Biodelivery Sciences International Inc achieved in the IV. Quarter 2021 below company average Revenue increase of 5.02% quarter on quarter, to $ 43.15 millions.

Within Major Pharmaceutical Preparations industry 140 other companies have achieved higher Revenue quarter on quarter growth. While Biodelivery Sciences International Inc 's Revenue growth quarter on quarter, overall rank is 1823.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #141
Healthcare Sector #333
Overall #1823
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #141
Healthcare Sector #333
Overall #1823
Revenue Q/Q Growth Statistics
High Average Low
2508.02 % 115.21 % -90.56 %
(Dec 31 2015)  


BDSI's IV. Quarter Q/Q Revenue Comment
Biodelivery Sciences International Inc achieved in the IV. Quarter 2021 below company average Revenue increase of 5.02% quarter on quarter, to $ 43.15 millions.

Within Major Pharmaceutical Preparations industry 140 other companies have achieved higher Revenue quarter on quarter growth. While Biodelivery Sciences International Inc 's Revenue growth quarter on quarter, overall rank is 1823.


Biodelivery Sciences International Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)		 12 Months Ending
(Mar 31 2021)		 12 Months Ending
(Dec 31 2020)
Cumulative Revenue 12 Months Ending $ 166.70 $ 165.72 $ 164.07 $ 159.21 $ 156.47
Y / Y Revenue Growth (TTM) 6.54 % 13.55 % 19.93 % 22.57 % 40.47 %
Year on Year Revenue Growth Overall Ranking # 965 # 1838 # 1174 # 304 # 210
Seqeuential Revenue Change (TTM) 0.59 % 1.01 % 3.05 % 1.75 % 7.22 %
Seq. Revenue Growth (TTM) Overall Ranking # 2798 # 2749 # 1683 # 2159 # 506


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2021 period, Biodelivery Sciences International Inc 's cumulative twelve months Revenue were $ 167 millions, company would post below average annual Revenue growth of 7.22% year on year, if the fiscal year would end at Dec 31 2021.
A slow-down in the Biodelivery Sciences International Inc 's Revenue growth from the 41.09% growth in Sep 30 2021.

In the Healthcare sector 194 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 965, from total ranking in previous quarter at 1838.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 144
Healthcare Sector # 195
Overall # 965

Revenue TTM Y/Y Growth Statistics
High Average Low
348.31 %
 49.93 %
-74.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 144
Sector # 399
S&P 500 # 2798
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2021 period, Biodelivery Sciences International Inc 's cumulative twelve months Revenue were $ 167 millions, company would post below average annual Revenue growth of -74.23% year on year, if the fiscal year would end at Dec 31 2021.
A slow-down in the Biodelivery Sciences International Inc 's Revenue growth from the 41.09% growth in Sep 30 2021.

In the Healthcare sector 194 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 965, from total ranking in previous quarter at 1838.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 144
Healthcare Sector # 195
Overall # 965

Revenue TTM Y/Y Growth Statistics
High Average Low
348.31 %
49.93 %
-74.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 144
Sector # 399
S&P 500 # 2798




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BDSI's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2021
Myriad Genetics Inc 4.01%$ 4.010 millions
Healthlynked Corp3.98%$ 3.979 millions
Endo International Plc3.84%$ 3.842 millions
Irhythm Holdings Inc 3.80%$ 3.800 millions
Jrsis Health Care Corp3.78%$ 3.782 millions
Infinity Pharmaceuticals Inc 3.68%$ 3.678 millions
Curis Inc 3.67%$ 3.671 millions
Community Health Systems Inc 3.66%$ 3.655 millions
Ligand Pharmaceuticals Incorporated3.55%$ 3.548 millions
Nuvasive Inc3.52%$ 3.519 millions
The Pennant Group Inc 3.52%$ 3.518 millions
Chemed Corporation3.39%$ 3.386 millions
Inogen Inc 3.28%$ 3.278 millions
Bioadaptives Inc 3.22%$ 3.216 millions
Amgen Inc 3.20%$ 3.196 millions
Surmodics Inc 3.17%$ 3.166 millions
Cano Health Inc 3.03%$ 3.030 millions
Inhibrx Biosciences Inc 2.88%$ 2.882 millions
Global Cord Blood Corp2.60%$ 2.604 millions
23andme Holding Co2.55%$ 2.549 millions
Personalis Inc 2.51%$ 2.508 millions
Viemed Healthcare Inc 2.44%$ 2.436 millions
Integrated Biopharma Inc2.36%$ 2.364 millions
Biodelivery Sciences International Inc 2.33%$ 2.334 millions
Neuropace Inc 2.28%$ 2.279 millions
Lifeward ltd 1.97%$ 1.970 millions
Scorpius Holdings inc 1.64%$ 1.643 millions
Fresenius Medical Care Ag1.62%$ 1.616 millions
Exact Sciences Corporation1.60%$ 1.602 millions
Bionik Laboratories Corp 1.60%$ 1.602 millions


About Biodelivery Sciences International Inc Revenue Growth Rates (BDSI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Biodelivery Sciences International Inc (CIK 1103021).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001103021-22-000051
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Biodelivery Sciences International Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.